+1 858 550 6152 msilverman@cooley.com
Matt Silverman focuses on mergers and acquisitions, general corporate matters and securities law. Matt regularly advises publicly traded companies with respect to corporate governance, takeover preparedness and SEC reporting.
Download full bio
One Medical Agrees to Acquire Iora Health in $2.1 Billion Transaction
IonQ Agrees to SPAC Merger With dMY Technology Group III
Nuvation Bio to Combine With Panacea, a Special Purpose Acquisition Company
Horizon Therapeutics to Acquire Viela Bio
Principia Biopharma Agrees to Sell to Sanofi for Approximately $3.68 Billion
View all
Mergers & Acquisitions
Film, Music, Surfing and Travel
Fordham University School of Law JD, cum laude, 2012
University of VermontBA, Economics and Political ScienceHonors Program, 2006
California
New York
One Medical Agrees to Acquire Iora Health in $2.1 Billion Transaction June 9, 2021
IonQ Agrees to SPAC Merger With dMY Technology Group III March 19, 2021
Horizon Therapeutics to Acquire Viela Bio to Grow Rare Disease Medicine Portfolio February 5, 2021
+1 858 550 6152 office msilverman@cooley.com
4401 Eastgate MallSan Diego, CA 92121-1909